Effect of Bupivacaine Application on Postthyroidectomy Pain
Bupivacaine Application Reduces Postthyroidectomy Pain: Cerrahpaşa Experience
Investigators aimed to evaluate the impact of bupivacaine administration into the surgical field after total thyroidectomy on post-operative pain and analgesic requirement with a double-blind, prospective, clinical, randomized study.
Pain assessment was performed with the visual analog score (VAS). Participants were pre-operatively, divided into two groups randomly to receive either bupivacaine or not. One group received a 10 ml of bupivacaine solution while the other group was treated with the same volume of 0.9% sodium chloride (NaCl) through the drain after completion of total thyroidectomy procedure. All participants were anesthetized and operated with the same anesthesia and surgical team.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Istanbul、七面鳥、34098
- Istanbul University, Cerrahpasa Medical Faculty
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Subjects need to be operated for thyroid diseases
Exclusion Criteria:
- History of previous thyroid disease,
- History of previous neck operations,
- Hypersensitivity to the drugs that were used in the study protocol,
- Spinal bone disease,
- Depression,
- Kidney failure,
- Heart failure,
- Liver failure,
- Pulmonary failure,
- Mental retardation,
- Subjects not able to ascertain pain scoring with the visual analog score (VAS),
- Patients with American Society of Anesthesiologists (ASA) scores III or higher,
- Expected airway difficulty according to Mallampati scores,
- Sedative, steroid, and chronic analgesic drug users,
- Alcoholics
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Bupivacaine
bupivacaine 0.5%, 10cc was administered to surgical field after completion of Thyroidectomy and approximately 15-30 minutes before the extubation.
|
Thyroidectomy performed by the same surgical and anesthesia team
bupivacaine 0.5%, 10cc was administered to surgical field after completion of Thyroidectomy and approximately 15-30 minutes before the extubation.
|
|
プラセボコンパレーター:Saline
Saline solution (%0.9 sodium chloride), 10cc was administered to surgical field after completion of Thyroidectomy and approximately 15-30 minutes before the extubation.
|
Thyroidectomy performed by the same surgical and anesthesia team
%0.9 sodium chloride solution, 10cc was administered to surgical field after completion of Thyroidectomy and approximately 15-30 minutes before the extubation.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Post-operative pain in 8 hours after surgery using VAS
時間枠:8th hour
|
Evaluation of the pain through the post-operative first 8 hours using VAS
|
8th hour
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Post-operative pain in in first post-operative day using VAS
時間枠:1 day
|
Evaluation of the pain through the first post-operative day using VAS
|
1 day
|
協力者と研究者
スポンサー
捜査官
- スタディチェア:Yusuf BUKEY, Prof. MD、Istanbul University
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。